Gestational diabetes mellitus: Where are we now?

Eran Ashwal, Moshe Hod

Research output: Contribution to journalArticlepeer-review

Abstract

Gestational diabetes mellitus (GDM) is defined as any carbohydrate intolerance first diagnosed during pregnancy. The prevalence of GDM is about 2-5% of normal pregnancies and depends of the prevalence of same population to type 2 diabetes mellitus. It is associated with adverse outcome for the mother, the fetus, neonate, child and adult offspring of the diabetic mother. Detection of GDM lies on screening, followed as necessary by diagnostic measures. Screening can either be selective, based upon risk stratification or universal. Timely testing enables the obstetrician to assess glucose tolerance in the presence of the insulin-resistant state of pregnancy and permits treatment to begin before excessive fetal growth has occurred. Once a diagnosis of GDM was made close perinatal surveillance is warranted. The goal of treatment is reducing fetal-maternal morbidity and mortality related with GDM. The exact glucose values needed are still not absolutely proved. The decision whether and when to induce delivery depends on gestational age, estimated fetal weight, maternal glycemic control and bishop score. Future research is needed regarding prevention of GDM, treatment goals and effectiveness of interventions, guidelines for pregnancy care and prevention of long term metabolic sequel for both the infant and the mother.

Original languageEnglish
Pages (from-to)14-20
Number of pages7
JournalClinica Chimica Acta
Volume451
DOIs
StatePublished - 7 Dec 2015
Externally publishedYes

Keywords

  • Gestational diabetes pregnancy
  • Pregnancy
  • Screening
  • Type 2 diabetes mellitus

Fingerprint

Dive into the research topics of 'Gestational diabetes mellitus: Where are we now?'. Together they form a unique fingerprint.

Cite this